Blau syndrome is an extremely rare autoimmune disease estimated to occur in fewer than one in a million people. Patients begin to show symptoms before the age of 4, and the symptoms will progress to cause serious complications ...
Jun 25, 2021
0
6
Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy and trastuzumab, according to results presented here at ...
Dec 11, 2013
0
0
The Food and Drug Administration has approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.
Nov 1, 2013
0
0
Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University ...
Feb 29, 2012
0
0
How do initially benign forms of cancer evolve to become aggressive? In a quest to answer this long-standing question, an EU project has studied the growth and clonal evolution of chronic lymphocytic leukaemia (CLL)—a blood ...
Aug 11, 2017
0
0
Updated data on the first 134 chronic lymphocytic leukemia patients treated with single-agent acalabrutinib shows that the drug was well-tolerated in the majority of patients treated and responses were durable over time, ...
Dec 13, 2017
0
3
A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In ...
May 28, 2014
0
0
New research suggests that young patients with acute lymphocytic leukemia (ALL)—the most common type of pediatric cancer—and their and their parents are likely to report to their physician that they took more of their ...
Feb 2, 2017
0
0
Increasing knowledge about genomic biomarkers has facilitated better monitoring and personalized management of patients with B-cell malignant tumors. A new integrative, capture-based, next-generation sequencing (NGS) panel, ...
Jul 29, 2021
0
0
Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the 50th Annual Meeting of the American ...
Jun 2, 2014
0
0
